AGQ Labs’ Post

💊 The importance of #bioequivalence studies in modern pharmaceuticals Bioequivalence means that two drugs — typically a generic and its reference version — release the same active ingredient in the same amount and at a similar rate. ✅ To confirm this, controlled clinical studies measure drug concentration in plasma over time, analyzing key pharmacokinetic parameters such as: - AUC (Area Under the Curve) - Cmax (Maximum Concentration) - Tmax (Time to Reach Maximum Concentration) When these values align, both drugs can be considered therapeutically equivalent. 👉 https://lnkd.in/d8uCF5kW Bioequivalence studies ensure that generic medicines are just as effective and safe as their original versions. 🔬 Laboratories like Netpharmalab are key players in this process. With advanced #analytical technology and multidisciplinary teams, they conduct rigorous, compliant bioequivalence studies that accelerate the availability of safe and reliable generics worldwide. #Spain #PharmaceuticalIndustry #GenericDrugs #ClinicalResearch #PharmaInnovation #DrugDevelopment #HealthcareAccess